Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model.
Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model.
复制标题
早期全身突变亨廷顿蛋白降低可避免蛋白质和脂质的变化,这对 LacQ140 小鼠模型中的突触功能和白质维持很重要。
DOI:
10.1101/2023.01.26.525697
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Kegel-Gleason,KimberlyB
中科院分区:
文献类型:
--
作者:
Shing,Kai;Sapp,Ellen;Boudi,Adel;Liu,Sophia;Seeley,Connor;Marchionini,Deanna;DiFiglia,Marian;Kegel-Gleason,KimberlyB
Expansion of a triplet repeat tract in exon 1 of theHTTgene causes Huntington’s disease (HD). The mutant HTT protein (mHTT) has numerous aberrant interactions with diverse, pleiomorphic effects. Lowering mHTT is a promising approach to treat HD, but it is unclear when lowering should be initiated, how much is necessary, and what duration should occur to achieve benefits. Furthermore, the effects of mHTT lowering on brain lipids have not been assessed. Using a mHtt-inducible mouse model, we analyzed mHttlowering initiated at different ages and sustained for different time-periods. mHTT protein in cytoplasmic and synaptic compartments of the striatum was reduced 38-52%; however, there was minimal lowering of mHTT in nuclear and perinuclear regions where aggregates formed at 12 months of age. Total striatal lipids were reduced in 9-month-old LacQ140 mice and preserved by mHttlowering. Subclasses important for white matter structure and function including ceramide (Cer), sphingomyelin (SM), and monogalactosyldiacylglycerol (MGDG), contributed to the reduction in total lipids. Phosphatidylinositol (PI), phosphatidylserine (PS), and bismethyl phosphatidic acid (BisMePA) were also changed in LacQ140 mice. Levels of all subclasses except ceramide were preserved by mHttlowering. mRNA expression profiling indicated that a transcriptional mechanism contributes to changes in myelin lipids, and some but not all changes can be prevented by mHttlowering. Our findings suggest that early and sustained reduction in mHttcan prevent changes in levels of select striatal proteins and most lipids, but a misfolded, degradation-resistant form of mHTT hampers some benefits in the long term.